Concepedia

Publication | Closed Access

Rituximab as treatment for anti-MuSK myasthenia gravis

DOI

243

Citations

18

References

2017

Year

Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar, Carolina Barnett, Nicholas J. Silvestri, James F. Howard, Diantha B. Howard, Amy Visser, Brian A. Crum, Richard J. Nowak,
Neurology

Abstract

This study provides Class IV evidence that for patients with anti-MuSK MG, rituximab increased the probability of a favorable outcome.

References

YearCitations

Page 1